Press Release / Media Release
Zydus receives final approval from the USFDA for Doxycycline for Injection USP.30-09-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Doxycycline for Injection USP.Zydus Cadila gets final nod from USFDA for anti-bacteria drug
Zydus Cadila has received final approval from the US food and drug administration (USFDA) to market doxycycline tablets, used for treatment of different types of bacterial infectionsPress Release / Media Release
Zydus receives final approval from the USFDA for Doxycycline Tablets USP.Zydus Cadila gets USFDA nod for anti-inflammatory drug
Zydus Cadila has received final approval from the US health regulator to market indomethacin extended release capsules used in treating painful and inflammatory conditions such as arthritis. The...Press Release / Media Release
Zydus receives final approval from the USFDA for Indomethacin Extended-Release Capsules USPZydus Cadila gets USFDA nod to sell hypertension drug
The group has now more than 150 approvals and has so far filed over 300 abbreviated new drug applicationsPress Release / Media Release
Zydus receives final approval from the USFDA for Amlodipine and Olmesartan Medoxomil TabletsPress Release / Media Release
Zydus receives final approval from the USFDA for Itraconazole Capsules 100 mg.Zydus Cadila gets final FDA nod for skin disorder, hypertension drugs
While Desoximetasone ointment is used for treatment of symptoms of a skin disease, Labetalol hydrochloride tablets are used for the treatment of high blood pressurePress Release / Media Release
Zydus receives final approval from the USFDA for Desoximetasone Ointment and Labetalol Hydrochloride Tablets